Google, Apple Struggle to Regulate Covid-19 Tracing Apps
Posted onResearch Assistant Position: costs of trade and regulatory barriers to access to medicines
Posted onCall for Applications: Research Assistant: costs of trade and regulatory barriers to access to medicines Description: Global Access in Action (GAiA) is a dynamic global health non-profit organization that focuses on improving access to lifesaving medicines in vulnerable populations through the implementation of legal, policy, and regulatory reform. We work with key domestic and international […]
At the Mercy of a Few: Patents, Market Concentration and Global Access to Medicines
Posted onMarket concentration in high-technology industries has become a subject of interest to scholars and policy analysts. This talk presents some of the first empirical results on how the patenting system contributes to market concentration in the pharma and chemical sectors globally. Please RSVP Thursday February 21, 2019 at noon Harvard Law School Wasserstein Hall Room […]
Access to Medicines: the 21st-century Global Health Challenge
Posted onTuesday 01/22/2019 Conference room at 12:00 pm Berkman Klein Center for Internet and Society Some 2 billion people worldwide do not have access to medicines. It is estimated that 3.6 million people died in 2016 because they had no access to health care and 5 million people died, despite having access to health care, because the […]
Upcoming Panel: Substandard and Counterfeit Medicines in Africa: A Human Rights Perspective
Posted onMarking 70 years of the Universal Declaration of Human Rights. Join Global Access in Action on the International Human Rights Day Celebration to discuss how to improve access to medicines in Africa. Panelists: Ashveena Gajeelee (GAiA); Bright Simons (Founder mPedigree); Rick Wolthusen (Co-founder On the Move e.V; and Helen Tesfaye (HSPH). Date: December 10, 2018 […]
Digital Health @ Harvard, November 27 : Computer Simulations to Enhance Vaccine Trials
Posted onNovember 27, 2018 12:00 PM Wasserstein Hall, Milstein East C (2036) Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Video and Podcast of the event (courtesy of Berkman Klein Center). Infectious disease emergencies are opportunities to test the efficacy of newly developed interventions—for example, drugs, vaccines, and treatment regimens. Yet they raise many intertwined challenges […]
Expanding Access to Medicines and Promoting Innovation: A Practical Approach
Posted onOn October 24, 2018, Global Access in Action (GAiA) in collaboration with the Petrie Flom Center held a conference on Drug Pricing Policies to assess the current challenges presented in drug pricing policy, from development to delivery. The conference was a follow up on the paper published in the Georgetown Journal on Poverty Law & Policy, where […]
Feeling the Pressure Points of the Indian Healthcare System
Posted onBy: Tanvi Kanchinadam Today, India is bearing witness to the most comprehensive piece of health reform legislation the world has ever seen. This legislation, known as the National Health Protection Mission, is part of the ambitious health care agenda of Prime Minister Narendra Modi. It is aimed at covering about 40% of India’s most vulnerable […]
Achieving Equitable Access to Vaccines: From Policies to Provisions
Posted onSpeaker: Julia Barnes-Weise, Executive Director of the Global Healthcare Innovation Alliances Accelerator Moderator: Ashveena Gajeelee On October 17, 2018, Julia Barnes-Weise, Executive Director of the Global Healthcare Innovation Alliances Accelerator (GHIAA)) a non-profit organization spun out of a program in Public Policy at Duke University, and a Senior Consultant to the Coalition for Epidemic Preparedness Innovations […]